MX2015009781A - Sistemas y metodos para soporte de decision clinica. - Google Patents

Sistemas y metodos para soporte de decision clinica.

Info

Publication number
MX2015009781A
MX2015009781A MX2015009781A MX2015009781A MX2015009781A MX 2015009781 A MX2015009781 A MX 2015009781A MX 2015009781 A MX2015009781 A MX 2015009781A MX 2015009781 A MX2015009781 A MX 2015009781A MX 2015009781 A MX2015009781 A MX 2015009781A
Authority
MX
Mexico
Prior art keywords
systems
methods
treatment
patient
present disclosure
Prior art date
Application number
MX2015009781A
Other languages
English (en)
Inventor
David B Jackson
Alexander Zien
Martin Stein
Alexander Picker
Theodoros Soldatos
Bernhard Sulzer
Stephan Brock
Guillaume Taglang
Original Assignee
Molecular Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48808311&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015009781(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2013/056963 external-priority patent/WO2013150039A1/en
Application filed by Molecular Health Gmbh filed Critical Molecular Health Gmbh
Publication of MX2015009781A publication Critical patent/MX2015009781A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioethics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Surgical Instruments (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)

Abstract

La presente descripción se refiere a sistemas y métodos para bioinformática y procesamiento de datos. En particular, en un primer aspecto, la presente descripción se refiere a métodos y sistemas para generar una directriz de tratamiento personalizada para un paciente y seleccionar un tratamiento para un paciente. En otro aspecto, la presente descripción se refiere a métodos y sistemas para seleccionar pacientes para un ensayo clínico de un tratamiento. La invención resuelve casos en los cuales los pacientes tienen más de una aberración "accionable" al combinar la información molecular específica de paciente y la información molecular específica de tratamiento adicionalmente con un modelo de enfermedad clínicomolecular, específicamente un registro de genes y/o proteínas que representan varios aspectos de su implicación en la enfermedad. De esta forma, se pueden priorizar tratamientos y pacientes que son más probables que impacten o sean impactados por el mecanismo de enfermedad, respectivamente.
MX2015009781A 2013-01-29 2013-10-01 Sistemas y metodos para soporte de decision clinica. MX2015009781A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361757805P 2013-01-29 2013-01-29
PCT/EP2013/056963 WO2013150039A1 (en) 2012-04-02 2013-04-02 Systems and methods for disease knowledge modeling and clinical decision support
PCT/EP2013/064621 WO2014117873A1 (en) 2013-01-29 2013-07-10 Systems and methods for clinical decision support
PCT/EP2013/070493 WO2014117875A1 (en) 2013-01-29 2013-10-01 Systems and methods for clinical decision support

Publications (1)

Publication Number Publication Date
MX2015009781A true MX2015009781A (es) 2016-06-16

Family

ID=48808311

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015009780A MX2015009780A (es) 2013-01-29 2013-07-10 Sistemas y metodos para soporte de decision clinica.
MX2015009781A MX2015009781A (es) 2013-01-29 2013-10-01 Sistemas y metodos para soporte de decision clinica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015009780A MX2015009780A (es) 2013-01-29 2013-07-10 Sistemas y metodos para soporte de decision clinica.

Country Status (14)

Country Link
US (2) US20150363559A1 (es)
EP (1) EP2951744A1 (es)
JP (3) JP2016514291A (es)
KR (2) KR20150113113A (es)
CN (2) CN105144179B (es)
AU (2) AU2013376459A1 (es)
BR (2) BR112015017954A2 (es)
CA (2) CA2899263A1 (es)
CL (2) CL2015002126A1 (es)
EA (2) EA201591411A1 (es)
IL (2) IL240127A0 (es)
MX (2) MX2015009780A (es)
SG (2) SG11201505852YA (es)
WO (2) WO2014117873A1 (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103119444B (zh) 2010-04-21 2016-10-26 米密德诊断学有限公司 区分细菌与病毒感染的标记物和决定因素以及其使用方法
US11398310B1 (en) 2010-10-01 2022-07-26 Cerner Innovation, Inc. Clinical decision support for sepsis
US10734115B1 (en) 2012-08-09 2020-08-04 Cerner Innovation, Inc Clinical decision support for sepsis
US10431336B1 (en) 2010-10-01 2019-10-01 Cerner Innovation, Inc. Computerized systems and methods for facilitating clinical decision making
US20120089421A1 (en) 2010-10-08 2012-04-12 Cerner Innovation, Inc. Multi-site clinical decision support for sepsis
US10628553B1 (en) 2010-12-30 2020-04-21 Cerner Innovation, Inc. Health information transformation system
US8856156B1 (en) 2011-10-07 2014-10-07 Cerner Innovation, Inc. Ontology mapper
US20170083669A1 (en) * 2012-01-20 2017-03-23 International Business Machines Corporation Method and apparatus providing an online diagnostic assistant tool
EP3367099B1 (en) 2012-02-09 2021-05-26 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US10249385B1 (en) 2012-05-01 2019-04-02 Cerner Innovation, Inc. System and method for record linkage
US11894117B1 (en) 2013-02-07 2024-02-06 Cerner Innovation, Inc. Discovering context-specific complexity and utilization sequences
US10946311B1 (en) 2013-02-07 2021-03-16 Cerner Innovation, Inc. Discovering context-specific serial health trajectories
US10769241B1 (en) 2013-02-07 2020-09-08 Cerner Innovation, Inc. Discovering context-specific complexity and utilization sequences
CA2908995A1 (en) * 2013-04-12 2014-10-16 Discus Analytics, Llc Medical treatment methods
WO2014194410A1 (en) * 2013-06-06 2014-12-11 Timeless Technologies (2007) Inc. Method and system for providing a treatment protocol
US12020814B1 (en) 2013-08-12 2024-06-25 Cerner Innovation, Inc. User interface for clinical decision support
US10957449B1 (en) 2013-08-12 2021-03-23 Cerner Innovation, Inc. Determining new knowledge for clinical decision support
US10483003B1 (en) 2013-08-12 2019-11-19 Cerner Innovation, Inc. Dynamically determining risk of clinical condition
US20150193583A1 (en) * 2014-01-06 2015-07-09 Cerner Innovation, Inc. Decision Support From Disparate Clinical Sources
CN106030623B (zh) * 2014-03-03 2019-07-09 爱克发医疗保健公司 用于术语推理的专用化机制
US20150331995A1 (en) * 2014-05-14 2015-11-19 Tiecheng Zhao Evolving contextual clinical data engine for medical data processing
CN107076746B (zh) * 2014-08-14 2020-05-29 米密德诊断学有限公司 使用流形和超平面进行生物学数据的计算机分析
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
CA2983562A1 (en) * 2015-04-29 2016-11-03 The University Of British Columbia Clinical support system and method
EP3297566A4 (en) * 2015-05-22 2019-02-20 CSTS Health Care Inc. BIOMARKER-CONTROLLED TARGETED MOLECULAR THERAPEUTIC COMBINATIONS BASED ON KNOWLEDGE REPRESENTATION PATH ANALYSIS
EP3298524A4 (en) 2015-05-22 2019-03-20 CSTS Health Care Inc. THERMODYNAMIC MEASUREMENTS RELATING TO PROTEIN-PROTEIN INTERACTION NETWORKS FOR THE TREATMENT OF CANCER
AU2016280074B2 (en) * 2015-06-15 2020-03-19 Nantomics, Llc Systems and methods for patient-specific prediction of drug responses from cell line genomics
JP6700376B2 (ja) * 2015-07-29 2020-05-27 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 有意性が未知のバリアントに優先順位をつけるシステム及び方法
US20180344239A1 (en) * 2015-11-13 2018-12-06 Segterra, Inc. Managing Evidence-Based Rules
US20170162069A1 (en) * 2015-12-02 2017-06-08 Noom, Inc. Scalable population health management tools for clinicians
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
BR112018075407A2 (pt) * 2016-06-07 2019-03-19 Illumina, Inc. plataforma de análise genômica para executar uma segmentação de análise de sequência
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
GB201613318D0 (en) * 2016-08-02 2016-09-14 Univ Oxford Innovation Ltd System monitor and method of system monitoring
EP3287914A1 (de) * 2016-08-23 2018-02-28 Siemens Healthcare GmbH Ermittlung von ergebnisdaten auf basis von medizinischen messdaten aus verschiedenen messungen
US11434534B2 (en) 2016-09-08 2022-09-06 Curematch, Inc. Optimizing therapeutic options in personalized medicine
US10971254B2 (en) * 2016-09-12 2021-04-06 International Business Machines Corporation Medical condition independent engine for medical treatment recommendation system
US10818394B2 (en) 2016-09-28 2020-10-27 International Business Machines Corporation Cognitive building of medical condition base cartridges for a medical system
US10593429B2 (en) 2016-09-28 2020-03-17 International Business Machines Corporation Cognitive building of medical condition base cartridges based on gradings of positional statements
US11353456B2 (en) 2016-09-29 2022-06-07 Memed Diagnostics Ltd. Methods of risk assessment and disease classification for appendicitis
EP3519833A4 (en) 2016-09-29 2020-06-03 MeMed Diagnostics Ltd. PROGNOSTIC AND TREATMENT METHODS
US20200051698A1 (en) * 2016-11-03 2020-02-13 Koninklijke Philips N.V. Precision clinical decision support with data driven approach on multiple medical knowledge modules
US10607736B2 (en) 2016-11-14 2020-03-31 International Business Machines Corporation Extending medical condition base cartridges based on SME knowledge extensions
TWI607332B (zh) * 2016-12-21 2017-12-01 國立臺灣師範大學 Correlation between persistent organic pollutants and microRNAs station
CN106971071A (zh) * 2017-03-27 2017-07-21 为朔医学数据科技（北京）有限公司 一种临床决策支持系统及方法
US20180357383A1 (en) * 2017-06-07 2018-12-13 International Business Machines Corporation Sorting Medical Concepts According to Priority
AU2018282865A1 (en) * 2017-06-13 2019-12-19 Bostongene Corporation Systems and methods for generating, visualizing and classifying molecular functional profiles
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN107749312A (zh) * 2017-10-10 2018-03-02 阜阳师范学院 一种基于体外受精‑胚胎移植的管理控制系统
KR101962105B1 (ko) * 2017-10-13 2019-03-26 주식회사 유비케어 진료차트를 기록하는 장치 및 진료차트를 기록하는 방법
EP3480823A1 (en) * 2017-11-02 2019-05-08 Koninklijke Philips N.V. Clinical decision support
US10937551B2 (en) 2017-11-27 2021-03-02 International Business Machines Corporation Medical concept sorting based on machine learning of attribute value differentiation
CN111492437A (zh) * 2017-12-29 2020-08-04 英泰曲尔德直线有限公司 支持医学决策的方法和系统
CN108335756B (zh) * 2018-01-18 2022-05-24 中山大学 鼻咽癌数据库及基于所述数据库的综合诊疗决策方法
US11475995B2 (en) 2018-05-07 2022-10-18 Perthera, Inc. Integration of multi-omic data into a single scoring model for input into a treatment recommendation ranking
US11694800B2 (en) * 2018-05-09 2023-07-04 International Business Machines Corporation Medical diagnosis system with continuous learning and reasoning
US11574718B2 (en) * 2018-05-31 2023-02-07 Perthera, Inc. Outcome driven persona-typing for precision oncology
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
US11093883B2 (en) * 2018-08-03 2021-08-17 Camelot Uk Bidco Limited Apparatus, method, and computer-readable medium for determining a drug for manufacture
CN108804866B (zh) * 2018-08-21 2019-09-20 淮南师范学院 一种基于二元网络的心血管疾病药物与药靶的预测方法
WO2020074191A1 (en) * 2018-10-11 2020-04-16 Siemens Healthcare Gmbh Healthcare network
KR102167697B1 (ko) * 2018-11-08 2020-10-19 주식회사 쓰리빌리언 증상 유사도 측정기에 대한 성능 평가 시스템 및 방법
US11735320B2 (en) 2018-12-04 2023-08-22 Merative Us L.P. Dynamic creation and manipulation of data visualizations
US11721441B2 (en) * 2019-01-15 2023-08-08 Merative Us L.P. Determining drug effectiveness ranking for a patient using machine learning
US20220146491A1 (en) * 2019-04-10 2022-05-12 Hemex Health, Inc. Diagnostic testing devices, systems and methods
JP7404648B2 (ja) * 2019-04-25 2023-12-26 富士通株式会社 治療薬提示方法、治療薬提示装置、及び治療薬提示プログラム
EP3984037A1 (en) * 2019-06-13 2022-04-20 F. Hoffmann-La Roche AG Systems and methods with improved user interface for interpreting and visualizing longitudinal data
CN110364266A (zh) * 2019-06-28 2019-10-22 深圳裕策生物科技有限公司 用于指导临床肿瘤个体化用药的数据库及其构建方法和装置
EP3799057A1 (en) * 2019-09-25 2021-03-31 Koninklijke Philips N.V. Prediction tool for patient immune response to a therapy
EP3799051A1 (en) * 2019-09-30 2021-03-31 Siemens Healthcare GmbH Intra-hospital genetic profile similar search
US11730420B2 (en) 2019-12-17 2023-08-22 Cerner Innovation, Inc. Maternal-fetal sepsis indicator
CN111259112B (zh) * 2020-01-14 2023-07-04 北京百度网讯科技有限公司 医疗事实的验证方法和装置
CN113496768B (zh) * 2020-03-20 2023-12-01 梅傲科技(广州)有限公司 基于病理组织的二联综合肿瘤分析系统和应用
EP4133109A4 (en) * 2020-04-10 2024-06-26 The Jackson Laboratory SYSTEMS AND METHODS FOR GENE VARIANT VISUALIZATION AND CLUSTERING
JP2022069002A (ja) * 2020-10-23 2022-05-11 株式会社日立製作所 治療方針立案支援装置
US12014281B2 (en) 2020-11-19 2024-06-18 Merative Us L.P. Automatic processing of electronic files to identify genetic variants
CN112735520B (zh) * 2021-02-03 2021-07-20 深圳裕康医学检验实验室 肿瘤个体化免疫治疗基因检测结果的解读方法、系统和存储介质
US20220261668A1 (en) * 2021-02-12 2022-08-18 Tempus Labs, Inc. Artificial intelligence engine for directed hypothesis generation and ranking
US20220399092A1 (en) * 2021-06-10 2022-12-15 Rajant Health Inc. Ai-enabled health platform
CN113724806A (zh) * 2021-08-03 2021-11-30 邢传华 确定临床试验入组对象、适用药物的方法、设备和介质
CN113889279B (zh) * 2021-09-28 2022-08-05 北京华彬立成科技有限公司 联合疗法信息挖掘和查询方法、装置和电子设备
TWI796228B (zh) 2022-05-25 2023-03-11 臺中榮民總醫院 急性腎損傷預測系統及其方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6108635A (en) * 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
JP2002510817A (ja) * 1998-04-03 2002-04-09 トライアングル・ファーマシューティカルズ，インコーポレイテッド 治療処方計画の選択をガイドするためのシステム、方法及びコンピュータ・プログラム製品
US6581038B1 (en) * 1999-03-15 2003-06-17 Nexcura, Inc. Automated profiler system for providing medical information to patients
EP1176539A1 (en) * 2000-07-13 2002-01-30 Virology Networks B.V. Method for effecting computer implemented decision-support in the selection of the drug therapy of patients having a viral disease
EP1358616A2 (en) * 2000-11-02 2003-11-05 Epigenomics AG Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the dna
AU2003201741A1 (en) * 2002-01-09 2003-07-24 Yusuke Nakamura Cancer profiles
JP3903420B2 (ja) 2002-02-14 2007-04-11 国立国際医療センター総長 塩基配列からｒｎａの機能性部位を同定するシステム
JP3563394B2 (ja) 2002-03-26 2004-09-08 株式会社日立製作所 画面表示システム
EP1378853A1 (fr) * 2002-07-04 2004-01-07 GE Medical Systems Global Technology Company LLC Système numérique d'assistance médicale
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
JP2006323830A (ja) 2005-04-18 2006-11-30 Japan Biological Informatics Consortium 表現型に関連する候補遺伝子の探索システム
EP2204454A1 (en) 2005-05-04 2010-07-07 University of South Florida Predicting treatment response in cancer subjects
JP2009517186A (ja) * 2005-11-29 2009-04-30 チルドレンズ ホスピタル メディカル センター 薬物選択及び投薬の最適化及び個別化
US20070238094A1 (en) 2005-12-09 2007-10-11 Baylor Research Institute Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
IL282783B2 (en) * 2006-05-18 2023-09-01 Caris Mpi Inc A system and method for determining a personalized medical intervention for a disease stage
US9353415B2 (en) 2006-12-19 2016-05-31 Thomson Reuters (Scientific) Llc Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom
AU2009210848B2 (en) * 2008-02-08 2013-12-19 Phadia Ab Method, computer program product and system for enabling clinical decision support
KR20170097234A (ko) * 2008-12-10 2017-08-25 더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 유방암 재발 예방용 백신
GB0912190D0 (en) * 2009-07-13 2009-08-26 Univ Surrey Biomarker
JP5744877B2 (ja) * 2009-09-04 2015-07-08 コーニンクレッカ フィリップス エヌ ヴェ 臨床判断支援のためのシステム及びその方法
US20130316338A1 (en) 2010-06-29 2013-11-28 The United States Government As Represented By The Department Of Veterans Affairs CCR6 As A Biomarker of Alzheimer's Disease
US20120016594A1 (en) 2010-07-02 2012-01-19 Coriell Institute For Medical Research, Inc. Method for translating genetic information for use in pharmacogenomic molecular diagnostics and personalized medicine research
US20120172674A1 (en) * 2010-12-30 2012-07-05 General Electronic Company Systems and methods for clinical decision support

Also Published As

Publication number Publication date
JP2018139111A (ja) 2018-09-06
EP2951744A1 (en) 2015-12-09
EA201591411A1 (ru) 2016-01-29
CN105144179A (zh) 2015-12-09
CN105144179B (zh) 2019-05-17
JP2016514291A (ja) 2016-05-19
US20150363559A1 (en) 2015-12-17
JP6662933B2 (ja) 2020-03-11
KR20150113113A (ko) 2015-10-07
AU2013376459A1 (en) 2015-08-06
BR112015017858A2 (pt) 2017-07-11
SG11201505852YA (en) 2015-08-28
CL2015002126A1 (es) 2016-06-17
SG11201505854QA (en) 2015-08-28
CN105144178B (zh) 2018-11-27
CN105144178A (zh) 2015-12-09
US20150370982A1 (en) 2015-12-24
IL240127A0 (en) 2015-09-24
JP2016513303A (ja) 2016-05-12
CL2015002127A1 (es) 2016-06-17
CA2899264C (en) 2021-05-11
MX2015009780A (es) 2016-04-04
CA2899263A1 (en) 2014-08-07
WO2014117875A1 (en) 2014-08-07
KR20150120390A (ko) 2015-10-27
JP6305437B2 (ja) 2018-04-04
EA201591412A1 (ru) 2015-12-30
US10672514B2 (en) 2020-06-02
WO2014117873A1 (en) 2014-08-07
AU2013376380A1 (en) 2015-08-06
IL240128A0 (en) 2015-09-24
CA2899264A1 (en) 2014-08-07
BR112015017954A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
MX2015009781A (es) Sistemas y metodos para soporte de decision clinica.
WO2014049527A3 (en) Personalizing patient pathways based on individual preferences, lifestyle regime, and preferences on outcome parameters to assist decision making
NZ762886A (en) Control system for control of distribution of medication
WO2017116817A3 (en) Testing of medicinal drugs and drug combinations
WO2011139345A3 (en) Pathway recognition algorithm using data integration on genomic models (paradigm)
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
MX2016002152A (es) Metodo para aumentar la expresion de proteinas codificadas por arn.
UA115034C2 (uk) Імунокон'югат для застосування в лікуванні раку або запального порушення
MX357803B (es) Moléculas de ácido nucleico artificiales.
UA106756C2 (uk) Генетичні маркери, асоційовані з відповіддю на інтерферон-альфа
UA115657C2 (uk) Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла
BR112017024091A2 (pt) métodos para o armazenamento de sangue total e composições do mesmo
MX2015012176A (es) Metodos de usar zscan4 para rejuvenecer celulas humanas.
BR112019004594A2 (pt) terapia genética para pacientes com anemia de fanconi
BR112014027087A2 (pt) tablete, método para fabricação de um tablete de mesilato de bromocriptina, método para fabricação de um tablete de mesilato de bromocriptina e método de tratamento para melhorar o controle glicêmico de diabetes do tipo 2 em um paciente
CY1120084T1 (el) Oλiγονουκλεοτiδiα για τη ρυθμιση της γονιδιακης εκφρασης και οι χρησεις αυτων
BR112015010220A2 (pt) métodos de utilização de biomarcadores para tratamento de câncer
WO2012135365A3 (en) Systems and methods for use in treating sensory impairment
EA201401353A1 (ru) Биомаркеры для определения эффективной ответной реакции на лечение пациентов с гепатоцеллюлярной карциномой (гцк)
BR112014025768A2 (pt) métodos de tratamento de espondilite anquilosante usando antagonistas de il-17
WO2012109233A3 (en) Methods for predicting recurrence risk in breast cancer patients
WO2011066082A3 (en) Markers associated with ribavirin-induced anemia
EA201491780A1 (ru) Мутанты c-raf, придающие резистентность к ингибиторам raf
BR112015017815A2 (pt) método para prever o início dos sintomas extrapiramidais (eps) induzidos por um tratamento a base de antipsicótico
WO2014145843A3 (en) Methods for treating cancer